NVO News

Recent headlines mentioning NVO, newest first.

NVO neutral

GreensKeeper Value Fund Q2 2026 Letter

seekingalpha.com·Jul 27, 2026·Zhanna Hapanovich/iStock via Getty Images Value in Action After a very slow start to the year, the Value Fund surged +10.9% in Q2, bringing its year-to-date r...
NVO bearish

Eli Lilly’s next-generation weight-loss shot clears another hurdle

livemint.com·Jul 23, 2026·Eli Lilly & Co.’s highly anticipated next-generation weight-loss shot didn’t increase overall heart risk in a new study, the company said, helping dispel li...
NVO bearish

Novo's cut-price Ozempic alternative lands in SA - one day after rival clears same hurdle

biznews.com·Jul 21, 2026·Vials on the Wegovy line at the Novo Nordisk A/S production facilities in Hillerod, Denmark Photographer: Carsten Snejbjerg/Bloomberg Health Novo's cut-price O...
NVO neutral

Is Most-Watched Stock Novo Nordisk A/S (NVO) Worth Betting on Now?

zacks.com·Jul 21, 2026·We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All...
NVO bullish

Novo Nordisk’s Rally Has Room To Run Driven By Oral Wegovy’s Momentum (NYSE:NVO)

seekingalpha.com·Jul 20, 2026·Since my last coverage , Novo Nordisk A/S ( NVO ) is up by about 27%, strongly outperforming the broader market. The most significant development is the growing...
NVO neutral

Novo Nordisk A/S - share repurchase programme

manilatimes.net·Jul 20, 2026·Bagsværd, Denmark, 20 July 2026 - On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of ...
NVO bullish

Wegovy Pill in Europe - Novo Nordisk Expands Franchise With First European Approval for Oral Weight Loss Drug

finance.yahoo.com·Jul 19, 2026·Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. The European Commission approved Novo Nordisk A/S' Wegovy ...
NVO bullish

Novo Nordisk: The Oral Wegovy Promise (NYSE:NVO)

seekingalpha.com·Jul 17, 2026·This is why it's at the heart of my investing group Green Growth Giants even though it's seen quite the pullback. But a rally is around the corner, as valuation...
NVO neutral

Tuberculosis Clinical Trial Pipeline Shows Potential with Active Contributions from 28+ Key Companies | DelveInsight

manilatimes.net·Jul 14, 2026·The tuberculosis clinical trial analysis report delivers important insights into ongoing research of 30+ pipeline tuberculosis drugs, clinical strategies, upcom...
NVO neutral

Novo Nordisk A/S - share repurchase programme

manilatimes.net·Jul 13, 2026·Bagsværd, Denmark, 13 July 2026 - On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of ...
NVO neutral

Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know

zacks.com·Jul 10, 2026·We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All...
NVO neutral

Novo Nordisk: Why I Don't Think The Story Is Broken (NYSE:NVO)

seekingalpha.com·Jul 9, 2026·Now, sure enough, Novo Nordisk A/S ( NVO ) has been a difficult hold. The stock is still down about 28% over the past year. But I don't want to throw in the tow...
NVO bearish

Inside THNR: A Leaner Approach to Weight Loss Investing

etftrends.com·Jul 7, 2026·Demand for GLP-1 weight loss drugs has reshaped the healthcare industry. And ETFs such as the Amplify Weight Loss Drug & Treatment ETF (THNR) give investors a w...
NVO neutral

Novo Nordisk Loses Its Edge, And I'm Downgrading (NYSE:NVO)

seekingalpha.com·Jul 7, 2026·With just one subscription to Beyond the Wall Investing , you can save thousands of dollars a year on equity research reports from banks. You'll keep your finge...
NVO neutral

Novo Nordisk A/S - share repurchase programme

manilatimes.net·Jul 6, 2026·Bagsværd, Denmark, 6 July 2026 - On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of t...
NVO bullish

Novo Nordisk (NVO) Upgraded to Buy at Nordea. Here is Why

finance.yahoo.com·Jul 1, 2026·With an annual dividend yield of 3.75%, Novo Nordisk A/S (NYSE:NVO) is included among the 12 Best NYSE Stocks to Buy for Dividends. Novo Nordisk (NVO) Upgraded...
NVO neutral

Novo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on It

zacks.com·Jun 29, 2026·We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All...
NVO neutral

Is Novo Nordisk (NVO) One of the Best Low Volatility Stocks to Buy Under $50?

finance.yahoo.com·Jun 27, 2026·Novo Nordisk A/S (NYSE:NVO) is one of the best low volatility stocks to buy under $50. Novo Nordisk A/S (NYSE:NVO) announced on June 11 that the Wegovy® pill h...
NVO neutral

Top Research Reports for Shell, Novo Nordisk & SAP

zacks.com·Jun 24, 2026·Wednesday, June 24, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports...
NVO bullish

Novo Nordisk: A Strong Yield And Continued Growth (NYSE:NVO)

seekingalpha.com·Jun 24, 2026·Retirement is complicated and you only get once chance to do it right. Don't miss out because you didn't know what was out there. The Retirement Forum provides...
NVO bullish

Novo Nordisk A/S (NVO) Primary Owner to Open Obesity Drug Incubators Across Europe

insidermonkey.com·Jun 23, 2026·When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard. Fast forward...
NVO neutral

Here is why Novo Nordisk A/S (NVO) is among the Best Longevity and Anti-Aging Stocks to Buy

finance.yahoo.com·Jun 22, 2026·With a short percentage of shares outstanding of 0.51%, Novo Nordisk A/S (NYSE:NVO) is among the 7 Best Longevity and Anti-Aging Stocks to Buy. On June 17, Ber...
NVO neutral

Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know

zacks.com·Jun 16, 2026·We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All...
NVO neutral

Biocon aims to become world’s top insulin supplier in five years

thehindubusinessline.com·Jun 16, 2026·Drugmaker Biocon Ltd. is aiming to become the world’s top supplier of insulin in the coming years, its co-founder Kiran Mazumdar-Shaw said, by capturing growi...
NVO neutral

Novo Nordisk A/S - share repurchase programme

manilatimes.net·Jun 15, 2026·Bagsværd, Denmark, 15 June 2026 - On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of ...
NVO neutral

Novo Nordisk A/S: IT Security incident at Novo Nordisk

manilatimes.net·Jun 11, 2026·Bagsværd, Denmark, 11 June 2026 - Novo Nordisk A/S has identified an IT security incident involving unauthorised access to a limited number of internal IT syst...
NVO neutral

Eli Lilly: Bears Are Missing The Underlying Thesis (NYSE:LLY)

seekingalpha.com·Jun 9, 2026·Eli Lilly and Company ( LLY ) has been the strongest performing big pharma company over the last year. It's up 50% in the last year compared to Novo Nordisk A/S...
NVO neutral

Novo Nordisk: The Biggest Healthcare Bargain (NYSE:NVO)

seekingalpha.com·Jun 8, 2026·Novo Nordisk A/S ( NVO ) has been up and down since I last covered it with my preview of its quarterly earnings , and I believe that it is only fair that As a ...
NVO neutral

Novo Nordisk A/S (NOVO:CA) Discusses Obesity and Diabetes Portfolio Progress and Pill Launch Milestones at R&D Event Transcript

seekingalpha.com·Jun 8, 2026·Presentation Michael Novod Senior VP & Head of Investor Relations All right. Good evening, and welcome to the 2026 Novo Nordisk Investor Event in connection ...
NVO bearish

Novo Nordisk CEO looks beyond weight loss to longevity and aesthetics

fortune.com·Jun 7, 2026·Novo Nordisk A/S Chief Executive Officer Mike Doustdar says the company’s blockbuster obesity drugs could ultimately pull it into increasingly buzzy areas of ...